🌀 Attention! Deal °86 IPO Prelude T. - for cancer treatment!
Stock market. Stocks. IPO Prelude Therapeutics — (PRLD) - September 25, 2020 on the American stock exchange will begin trading shares of the company (the deadline for submitting an application for participation with a broker is 20-00 Moscow time on 23.09.2020), which develops drugs for the treatment of cancer. The placement is underwritten by Morgan Stanley, Goldman Sachs and Bofasecuries. Company: Prelude Therapeutics (PLC) is a boutique Rating: 3 stars out scoop: 2 Oversubscription: 100% Allocation: up to 20%
2% of the Fund will be invested in shares of this company. Detailed reports on our paid subscription for all partners will be provided in PDF (additional data on request in PM)
2% of the Fund will be invested in shares of this company. Detailed reports on our paid subscription for all partners will be provided in PDF (additional data on request in PM)
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.